Here, we extend the significance of CNDP1 to that manifestation of clinical disease in MS by attributing the low levels of CNDP1 observed in MS patients predominantly to RR subtype in contrast to the near normal levels observed in PP. The gene discussed is CNDP1; the disease is myeloid sarcoma.